Follow
Jacob Leander
Jacob Leander
Clinical Pharmacology & Pharmacometrics, AstraZeneca R&D
Verified email at astrazeneca.com - Homepage
Title
Cited by
Cited by
Year
Stochastic differential equations as a tool to regularize the parameter estimation problem for continuous time dynamical systems given discrete time measurements
J Leander, T Lundh, M Jirstrand
Mathematical Biosciences 251, 54-62, 2014
48*2014
Mixed effects modeling using stochastic differential equations: illustrated by pharmacokinetic data of nicotinic acid in obese Zucker rats
J Leander, J Almquist, C Ahlström, J Gabrielsson, M Jirstrand
The AAPS journal 17, 586-596, 2015
462015
Using sensitivity equations for computing gradients of the FOCE and FOCEI approximations to the population likelihood
J Almquist, J Leander, M Jirstrand
Journal of pharmacokinetics and pharmacodynamics 42, 191-209, 2015
422015
Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trials
TH Myrbäck, S Prothon, K Edman, J Leander, M Hashemi, M Dearman, ...
The Lancet Rheumatology 2 (1), e31-e41, 2020
152020
Mathematical Modeling of Malaria: Methods for Simulation of Epidemics
P Johansson, J Leander
13*2010
Nonlinear mixed effects modeling of deterministic and stochastic dynamical systems in Wolfram Mathematica
J Leander, J Almquist, A Johnning, J Larsson, M Jirstrand
IFAC-PapersOnLine 54 (7), 409-414, 2021
112021
Joint feedback analysis modeling of nonesterified fatty acids in obese Zucker rats and normal Sprague–Dawley rats after different routes of administration of nicotinic acid
S Tapani, J Almquist, J Leander, C Ahlström, LA Peletier, M Jirstrand, ...
Journal of Pharmaceutical Sciences 103 (8), 2571-2584, 2014
112014
Exact Gradients Improve Parameter Estimation in Nonlinear Mixed Effects Models with Stochastic Dynamics
HK Olafsdottir, J Leander, J Almquist, M Jirstrand
The AAPS journal 20 (5), 88, 2018
92018
A semi-mechanistic exposure–response model to assess the effects of verinurad, a potent URAT1 inhibitor, on serum and urine uric acid in patients with hyperuricemia-associated …
J Leander, M Sunnåker, D Rekić, S Aksenov, UG Eriksson, S Johansson, ...
Journal of Pharmacokinetics and Pharmacodynamics 48, 525-541, 2021
82021
Estimation of equipotent doses for anti‐inflammatory effects of prednisolone and AZD9567, an oral selective non‐steroidal glucocorticoid receptor modulator
J Almquist, MW Sadiq, UG Eriksson, T Hegelund Myrbäck, S Prothon, ...
CPT: Pharmacometrics & Systems Pharmacology 9, 444-455, 2020
62020
A stochastic mixed effects model to assess treatment effects and fluctuations in home‐measured peak expiratory flow and the association with exacerbation risk in asthma
J Leander, M Jirstrand, UG Eriksson, R Palmér
CPT: Pharmacometrics & Systems Pharmacology, 2021
42021
Higher Febuxostat Exposure Observed in Asian Compared with Caucasian Subjects Independent of Bodyweight
D Rekić, S Johansson, J Leander
Clinical Pharmacokinetics 60 (3), 319-328, 2021
32021
NLMEModeling: a wolfram mathematica package for nonlinear mixed effects modeling of dynamical systems
J Leander, J Almquist, A Johnning, J Larsson, M Jirstrand
arXiv preprint arXiv:2011.06879, 2020
32020
SAT0245 Azd9567: a novel oral selective glucocorticoid receptor modulator, demonstrated to have an improved therapeutic ratio compared to prednisolone in pre-clinical studies …
R Hendrickx, T Hegelund-Myrbäck, M Dearman, S Prothon, G Edenro, ...
Annals of the Rheumatic Diseases 77 (Suppl 2), 984-985, 2018
22018
P138 Urinary leukotriene E4 (uLTE4) pharmacodynamic biomarker for early decision making in the AZD9898 adaptive phase i study
J Betts, B Larsson, A Jauhiainen, T Hegelund-Myrbäck, J Leander, ...
Thorax 73 (Suppl 4), A177-A177, 2018
12018
Latent Process Location-Scale Mixed-effects Model for Intensively Sampled Ordinal Patient Reported Outcomes
A Jauhiainen, A Król, J Leander, R Palmér, C Proust-Lima
NORDSTAT 2023, 2023
2023
Stochastic mixed effects modeling of home-measured peak expiratory flow and the association to exacerbation risk in asthma
J Leander, M Jirstrand, UG Eriksson, R Palmér
ACoP12, 2021
2021
Mixed Effects Modeling of Deterministic and Stochastic Dynamical Systems - Methods and Applications in Drug Development
J Leander
Mathematical Sciences, Chalmers University of Technology, Gothenburg, Sweden, 2021
2021
Estimation of equipotent doses of the oral selective glucocorticoid receptor modulator (oSGRM) AZD9567 and prednisolone based on ex vivo TNFa inhibition after LPS stimulation
J Almquist, J Leander, W Sadiq, TH Myrbäck, S Prothon, U Eriksson
Population Approach Group Europe (PAGE), 2019
2019
Higher Febuxostat Exposure observed in Japanese Compared to Caucasian Subjects Independent of Bodyweight
D Rekić, J Leander, S Johansson, U Eriksson
Population Approach Group Europe (PAGE), 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20